Mesa Nilda Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$819,591.92

Insider Activity of Mesa Nilda

According to the SEC Form 4 filings, Mesa Nilda, being in a position of

  1. director at United Therapeutics Corporation,
    оver the last 12 months, has bought 0 shares, and sold 673 shares for $355,542,
    over all time since 2022-09-28, has bought 0 shares, and sold 4440 shares for $1.36M.

Biography of Mesa Nilda

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$355,5423100

Comparison of Insiders on Amount of Buys and Sells

2026-09-14SaleUnited Therapeutics Corporation
UTHR
director
228
0.0005%
$505.87$115,338+7.78%
2026-05-12SaleUnited Therapeutics Corporation
UTHR
director
258
0.0006%
$581.93$150,139-7.37%
2025-12-09SaleUnited Therapeutics Corporation
UTHR
director
187
0.0004%
$481.63$90,065+11.26%
2025-06-24SaleUnited Therapeutics Corporation
UTHR
director
645
0.0014%
$289.99$187,045+64.22%
2024-12-30SaleUnited Therapeutics Corporation
UTHR
director
255
0.0006%
$355.77$90,720-9.38%
2024-11-08SaleUnited Therapeutics Corporation
UTHR
director
224
0.0005%
$412.28$92,350-20.98%
2024-06-25SaleUnited Therapeutics Corporation
UTHR
director
266
0.0006%
$318.58$84,742+8.14%
2024-03-27SaleUnited Therapeutics Corporation
UTHR
director
325
0.0007%
$237.80$77,285+41.82%
2023-12-19SaleUnited Therapeutics Corporation
UTHR
director
605
0.0013%
$244.90$148,165+29.93%
2023-09-13SaleUnited Therapeutics Corporation
UTHR
director
383
0.0008%
$222.36$85,164+6.58%
2023-05-05SaleUnited Therapeutics Corporation
UTHR
director
374
0.0008%
$214.81$80,337+6.57%
2022-11-07SaleUnited Therapeutics Corporation
UTHR
director
290
0.0006%
$268.57$77,886-13.7%
2022-09-28SaleUnited Therapeutics Corporation
UTHR
400
0.0009%
$207.36$82,943+8.87%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.